THPO and congenital secretory chloride diarrhea 1: Thirty patients received thrombopoietin or rhiL-11 as combination treatment, and the percentages of combination treatment were similar between the CLD and non-CLD groups (33.3% vs. 28.6%; P=0.794) (Table 1).